Adapted from UBC Research & Innovation
Three research projects involving the Faculty of Pharmaceutical Sciences at the University of British Columbia (UBC) have been supported by a total of just over $2.18M through the Project Grant: Spring 2020 Competition from the Canadian Institutes for Health Research (CIHR).
The following two projects are being led by faculty members:
Targeting TSLP - Novel anti-inflammatory compounds for the treatment and prevention of atopic diseases
Principal Investigator: Dr. Sarah Hedtrich
Co-Investigator: Dr. Brent Page
$803,250
Characterization of invadopodia formation in response to local cues and their role in orchestrating metastasis
Principal Investigator: Dr. Karla Williams (Canada Research Chair in Oncology)
$757,350
Dr. Urs Häfeli is a co-investigator on the following project, together with a group of researchers at the Université de Montréal:
Magnetic resonance navigation of drug eluting beads for liver cancer therapy: in-vitro optimization and preclinical safety efficacy study
$619,651
UBC researchers were awarded more than $19M for 27 projects being led at the university and its affiliated health authority research centres. As CIHR’s largest funding program, the Project Grant competitions support multi-year grants for researchers at various stages in their careers as they conduct research projects that cover the full range of health research topics.
“I extend my sincere congratulations to our researchers for their success,” says Dr. Michael Coughtrie, professor and dean. “The funding received from CIHR is an essential support that enables our talented faculty members to conduct cutting edge research that will have global impact.”
Through the Spring 2020 Project Grant competition, CIHR has funded 336 Full Project Grants, plus nine bridge grants, for a total investment of approximately $253 million. In addition, 16 priority announcement bridge grants were funded to a total amount of $1,460,000.